Výsledky vyhledávání - "Andrea N. Sitek"

Akademický článek

Risks and safety of biologics: A practical guide for allergists

Autor: Andrea N. Sitek, MD, James T. Li, MD, PhD, Thanai Pongdee, MD

Publikováno v: World Allergy Organization Journal, Vol 16, Iss 1, Pp 100737- (2023)

Biologic agents are a rapidly expanding class of medications, and several options are now available for the management of allergic and immunologic disorders. The risks of biologic therapy need to be understood in order to adequately counsel patients

Externí odkaz: https://doaj.org/article/78b4880e1a394915b560c25b49ce9207

Zobrazit plný text záznamu

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions

Autor: Mitchell M. Pitlick, Miguel A. Park, Alexei Gonzalez-Estrada, Kelley N. Dages, Michael D'Netto, Andrea N. Sitek, Avni Y. Joshi, Sergio E. Chiarella

Publikováno v: Annals of Allergy, Asthma & Immunology

Background The mechanism of coronavirus disease 2019 (COVID-19) vaccine hypersensitivity reactions is unknown. COVID-19 vaccine excipient skin testing has been used in evaluation of these reactions, but its utility in predicting subsequent COVID-19 v

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f0c7c645dd89f2e87a7c90ce840340
https://doi.org/10.1016/j.anai.2021.11.006

Zobrazit plný text záznamu

Outcomes among patients with COVID-19 and asthma: A systematic review and meta-analysis

Autor: Rohit Divekar, Avni Y. Joshi, Vivek N. Iyer, Zhen Wang, Mitchell M. Pitlick, Justine M. Ade, Andrea N. Sitek, Sergio E. Chiarella

Publikováno v: Allergy and Asthma Proceedings. 42:267-273

Background: It remains unclear if asthma is a risk factor associated with worse outcomes among patients with coronavirus disease 2019 (COVID-19). Methods: We performed a comprehensive database search for studies published from January 1, 2019, to Oct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d73644d9923ed0fb5e17f9f44c9aa47d
https://doi.org/10.2500/aap.2021.42.210041

Zobrazit plný text záznamu

Abstract A120: Sex differences in tolerability and response to immune checkpoint inhibitors in non-small cell lung cancer patients

Autor: Rami Manochakian, Roxana S. Dronca, Abdel Ghani Azzouqa, Kahterine Hoversten, Lisa A. Kottschade, Siddhartha Yadav, Jonas Paludo, Clay T Reed, Andrea N. Sitek, Elizabeth Ann L. Enninga, Alex A. Adjei, Aaron S. Mansfield, Narjust Duma

Publikováno v: Cancer Epidemiology, Biomarkers & Prevention. 29:A120-A120

Background: Sex differences in non-small cell lung cancer (NSCLC) outcomes have been described. Immune-related adverse events (IRAEs) have emerged as a serious clinical problem in the use of immune checkpoint inhibitors (ICI). Risk factors for IRAEs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::46f8f1d737fe9880f4a8073b596aa2f4
https://doi.org/10.1158/1538-7755.disp18-a120

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání